Clinical Trials in Massachusetts

Showing 5201-5220 of 13,570 trials

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

NCT04476472

Subjects will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 94-day (13-week) hybrid closed-loop phase conducted in an outpatient setting, and an optional 12-month extension phase.

Type 1 Diabetes Mellitus

Insulet Corporation80 participantsStarted Sep 2020

Palo Alto, California, United States • Denver, Colorado, United States • New Haven, Connecticut, United States +7 more locations

TERMINATEDPhase 326 miles

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780541

This study looks at the safety and effectiveness of PF-07304814 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either PF-07304814 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H6.

COVID-19

National Institute of Allergy and Infectious Diseases (NIAID)58 participantsStarted Sep 2021

Chula Vista, California, United States • Los Angeles, California, United States • Mather, California, United States +37 more locations

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Find Trials by Condition in Massachusetts

Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)

Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely

The Feasibility of VR for OUD

Practice of Acceptance, Awareness, and Compassion in Caregiving (PAACC)

Behavioral Economic Analysis of Demand for Marijuana

Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

Omnibond vs Dermabond

Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy

Actuate 1901: 9-ING-41 in Myelofibrosis

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)

A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

REDUCE LAP-HFREF TRIAL

Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Lung EpiCheck Biomarkers Development Study

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis